Idexx Laboratories (IDXX) Equity Ratio (2009 - 2026)

Idexx Laboratories' Equity Ratio history runs 18 years deep, the most recent figure standing at 0.46 for Q1 2026.

• In Q1 2026, Equity Ratio rose 2.01% year-over-year to 0.46; the TTM figure through Mar 2026 stood at 0.46 (up 2.01% YoY), while the FY2025 annual figure was 0.48, down 1.09% from the prior year.
• Equity Ratio was 0.46 for Q1 2026 at Idexx Laboratories, down from 0.48 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.48 in Q4 2024 to a low of 0.18 in Q2 2022.
• Historically, Equity Ratio has averaged 0.39 across 5 years, with a median of 0.45 in 2025.
• The sharpest annual moves came in 2022 and 2023: Equity Ratio tumbled 43.49% in 2022, then soared 133.15% in 2023.
• A 5-year view of Equity Ratio shows it stood at 0.22 in 2022, then soared by 105.48% to 0.46 in 2023, then increased by 6.37% to 0.48 in 2024, then retreated by 1.09% to 0.48 in 2025, then fell by 4.06% to 0.46 in 2026.
• The last three Equity Ratio figures came in at 0.46 (Q1 2026), 0.48 (Q4 2025), and 0.46 (Q3 2025), per Business Quant data.